Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Efficacy and Safety Profile of Lurbinectedin in Second-Line SCLC Patients: Results from a Phase II Single-Agent Trial.

Luis G. Paz-Ares,Jose Manuel Trigo Perez,Benjamin Besse,Victor Moreno,Rafael Lopez,Maria Angeles Sala,Santiago Ponce Aix,Cristian Marcelo Fernandez,Mariano Siguero,Carmen Maria Kahatt,Ali Hassan Zeaiter,Khalil Zaman,Valentina Boni,Jennifer Arrondeau,Maite Martinez Aguillo,Jean-Pierre Delord,Ahmad Awada,Rebecca Sophie Kristeleit,Maria Eugenia Olmedo Garcia,Vivek Subbiah

Journal of clinical oncology（2019）

Cited 37|Views104
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined